The Decipher genomic test could help doctors decide which high-risk prostate cancer patients need abiraterone hormone therapy ...

CLEVELAND, Ohio — A genomic test used to assess prostate cancer risk may also help doctors determine which patients are ...

It is easy to assume that the prostate is healthy when there is no usual discomfort during urination. However, prostate ...

Add Yahoo as a preferred source to see more of our stories on Google. b' Prostate cancer is the most common form of cancer among men in England, with cases surging by 25 per cent between 2019 and 2023 ...

A simple blood test to detect cancer before symptoms even appear: that’s the promise of liquid biopsy, a rapidly developing ...

Prostate cancer is the most common cancer in Australia, with about 26,000 men diagnosed per year. The majority (more than 85%) are aged over 60. Prostate cancer kills around 3,900 Australians a year.

Add Yahoo as a preferred source to see more of our stories on Google. Prostate cancer blood tests ‘can lead to men being over-tested’, experts say Prostate cancer blood tests can lead to men being ...

Prostate cancer is one of the most common cancers in the world. While many prostate cancers grow slowly and remain localized, other types are aggressive and spread quickly. That's why Dr. Carlos ...

Prostate cancer is the most common cancer in men – in 2013, it affected more than one million men across the world.

A systematic review of sixteen studies finds that emerging serum and urine protein biomarkers, including PHI, PSP94/PSA ratio ...

To check for possible prostate cancer, physicians most often use prostate-specific antigen (PSA) tests and digital rectal exams (DREs). For a firm diagnosis, they use core needle biopsies. This page ...

AstraZeneca has punted a pair of early-phase prostate cancer progra | AstraZeneca has punted a pair of early-phase prostate ...